| amphetamine/dextroamphetamine immediate release tablet / Generic mfg. |
NCT02058693: Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant Therapy |
|
|
| Completed | 4 | 41 | US | mixed salts amphetamine, Adderall | Rush University Medical Center | Major Depressive Disorder | 12/14 | 12/14 | | |
NCT02204410: Omega-3 Supplementation to ADHD Medication in Children |
|
|
| Completed | 4 | 21 | US | Omega-3 Fatty Acid, Fish Oil, Nordic Naturals Pro-Omega Junior Omega-3 Fatty Acid, Nordic Omega-3 Fishies, ADHD Medication, Stimulant, Concerta, Ritalin, Focalin, Vyvanse, Adderall, Dexedrine, Amphetamine, Methylphenidate, Stratterra, Tenex | Massachusetts General Hospital | Attention Deficit Hyperactivity Disorder, Deficient Emotional Self-Regulation | 05/16 | 08/16 | | |
NCT03530631: Neuroimaging the Expectancy Versus Pharmacotherapy Effect of Adderall on Cognitive Performance |
|
|
| Completed | 4 | 4 | US | Adderall, Placebo | University of Alabama at Birmingham | Expectancy Versus Pharmacotherapy Effect of Adderall | 12/18 | 12/18 | | |
2018-003271-35: STUDY OF ATTENTION AND IMPULSIVITY IN HEALTHY HUMAN VOLUNTEERS |
|
|
| Not yet recruiting | 4 | 100 | Europe | Tablet, Capsule, hard, Methylphenidat "Alternova", Atomoxetin "Actavis", Attentin, Modafinil "Orion" | University of Copenhagen, University of Copenhagen, Lundbeck Foundation, H. Lundbeck A/S | Attentional deficits and impulsive behaviour. These symptoms are common in attention deficit hyperactivity disorder, but also other conditions affecting the central nervous system such as Alzheimer's disease, schizophrenia, or depression and anxiety., Attention Deficit Hyperactivity Disorder and other conditions affecting attention and impulsivity, Psychiatry and Psychology [F] - Behaviours [F01] | | | | |
NCT05597722: Addressing Cognitive Fog in Long-COVID-19 Patients |
|
|
| Terminated | 4 | 7 | US | Digital cognitive behavioral intervention-RxWell, Amphetamine-Dextroamphetamine, Adderall | Eva Szigethy, The Beckwith Institute | Cognitive Impairment, Long COVID | 05/23 | 05/23 | | |
NCT04170738: Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder |
|
|
| Recruiting | 4 | 44 | US | Adderall, Dextroamphetamine-Amphetamine | Jeffrey Newcorn, National Institute on Drug Abuse (NIDA) | Attention Deficit Disorder With Hyperactivity, Conduct Disorder, Substance Abuse | 04/24 | 04/24 | | |
| Recruiting | 4 | 10 | US | Stimulant, Adderall, Concerta, Aptensio, Daytrana, Metadate, Quillivant, Ritalin, Focalin, Vyvanse | Matthew J O'Brien, PhD, BCBA-D | Attention Deficit Hyperactivity Disorder, Problem Behavior | 01/25 | 01/25 | | |
NCT04635826: The Role of Expectancy for Cognitive Enhancement in College Students Using Prescription Stimulants Nonmedically |
|
|
| Not yet recruiting | 4 | 100 | NA | Adderall 10Mg Tablet, Adderall, Placebo | University of Alabama at Birmingham | Prescription Stimulants, Expectations, Deception | 07/29 | 07/30 | | |
